Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung
7680661350015
CH-66135
Konzentrat
Associated product:
STELARA conc perf 130 mg/26ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
130.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.5 UGML | Substance | HBESI |
Reimbursement information
Public price
CHF 3360.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2017
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 66135
- Drug name
- Stelara, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L04AC05
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 02/06/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- STELARA conc perf 130 mg/26ml flac
- Description (DE)
- STELARA Inf Konz 130 mg/26ml Durchstf
- Market launch
- 02/06/2017
- Narcotic (BTM)
- No